A D S Diagnostic
Healthcare
523031 BSE
Price unavailable
No trades in 1Y
Key Insights
Strengths
5- Stock is trading at 0.33 times its book value
- Stock is providing a good dividend yield of 10.6%.
- Company has been maintaining a healthy dividend payout of 17.4%
- Debtor days have improved from 80.2 to 63.7 days.
- Company's working capital requirements have reduced from 76.9 days to 61.1 days
Weaknesses
1- Company's cost of borrowing seems high
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 2 | 11 | 6 |
| Oscillators | Bearish | 2 | 7 | 0 |
| Moving Averages | Strong Bullish | 0 | 4 | 6 |
Oscillators
Bearish
Bearish
2
Neutral
7
Bullish
0
Overall
Bullish
Bearish
2
Neutral
11
Bullish
6
Moving Averages
Strong Bullish
Bearish
0
Neutral
4
Bullish
6
Key readings
- RSI (14)
- 59.94
- Neutral
- MACD (12,26,9)
- 0.14
- Bearish
- SMA (50)
- 9.61
- Bullish
- SMA (200)
- —
- Neutral
As of , the latest day with price data, so these readings are not current.
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +9.34% |
|---|---|
| 5Y | +24.75% |
| 3Y | +28.94% |
| 1Y | +78.06% |
| TTM | +69.01% |
Net profit
| 10Y | +13.19% |
|---|---|
| 5Y | +25.77% |
| 3Y | +37.68% |
| 1Y | +32.10% |
| TTM | +9.09% |
Operating cash flow
| 10Y | Turned negative |
|---|---|
| 5Y | Turned negative |
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −3.64 pp |
|---|---|
| 5Y | +6.35 pp |
| 3Y | −3.88 pp |
| 1Y | −1.34 pp |
| TTM | −3.55 pp |
Revenue by year
| Mar 2017 | ₹5.26 Cr |
|---|---|
| Mar 2018 | ₹6.38 Cr |
| Mar 2019 | ₹8.95 Cr |
| Mar 2020 | ₹13.52 Cr |
| Mar 2021 | ₹9.43 Cr |
| Mar 2022 | ₹10.10 Cr |
| Mar 2023 | ₹13.29 Cr |
| Mar 2024 | ₹23.96 Cr |
| Mar 2025 | ₹16.00 Cr |
| Mar 2026 | ₹28.49 Cr |
Net profit by year
| Mar 2017 | −₹0.52 Cr |
|---|---|
| Mar 2018 | ₹0.21 Cr |
| Mar 2019 | ₹0.85 Cr |
| Mar 2020 | ₹0.47 Cr |
| Mar 2021 | ₹0.34 Cr |
| Mar 2022 | ₹0.44 Cr |
| Mar 2023 | ₹0.41 Cr |
| Mar 2024 | ₹1.85 Cr |
| Mar 2025 | ₹0.81 Cr |
| Mar 2026 | ₹1.07 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.25 | 7.72 | 7.12 | 5.95 | 4.2 | 5.96 | 2.6 | 3.37 | 4.4 | 14.59 | 5.46 | 4.04 | 3.51 |
| Expenses | 3.09 | 6.13 | 6.32 | 5.26 | 4.03 | 5.18 | 2.23 | 3.16 | 4.05 | 13.57 | 5 | 3.76 | 3.36 |
| Operating Profit | 0.16 | 1.59 | 0.8 | 0.69 | 0.17 | 0.78 | 0.37 | 0.21 | 0.35 | 1.02 | 0.46 | 0.28 | 0.15 |
| OPM % | 4.92% | 20.6% | 11.24% | 11.6% | 4.05% | 13.09% | 14.23% | 6.23% | 7.95% | 6.99% | 8.42% | 6.93% | 4.27% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0.07 | 0.19 | 0.16 | 0.16 | 0.04 | 0.12 | 0.08 | 0.06 | 0.12 | 0.18 | 0.18 | 0.13 | 0.1 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | −0.02 | 0.01 |
| PBT | 0.05 | 1.36 | 0.6 | 0.49 | 0.09 | 0.62 | 0.25 | 0.12 | 0.2 | 0.81 | 0.26 | 0.17 | 0.04 |
| Tax % | 0% | 22.06% | 30% | 34.69% | 22.22% | 24.19% | 24% | 41.67% | 25% | 25.93% | 23.08% | 35.29% | 25% |
| Net Profit | 0.04 | 1.06 | 0.42 | 0.33 | 0.07 | 0.47 | 0.19 | 0.07 | 0.15 | 0.61 | 0.2 | 0.12 | 0.03 |
| EPS (₹) | 0.18 | 4.83 | 1.92 | 1.5 | 0.32 | 2.14 | 0.87 | 0.32 | 0.68 | 2.78 | 0.91 | 0.55 | 0.14 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.44 | 11.67 | 5.26 | 6.38 | 8.95 | 13.52 | 9.43 | 10.1 | 13.29 | 23.96 | 16 | 28.49 | 27.6 |
| Expenses | 6.75 | 10.38 | 6.01 | 5.65 | 7.41 | 12.96 | 9.33 | 9.11 | 11.79 | 20.83 | 14.6 | 26.38 | 25.69 |
| Operating Profit | 0.69 | 1.29 | −0.75 | 0.73 | 1.54 | 0.56 | 0.1 | 0.99 | 1.5 | 3.13 | 1.4 | 2.11 | 1.91 |
| OPM % | 9.27% | 11.05% | −14.26% | 11.44% | 17.21% | 4.14% | 1.06% | 9.8% | 11.29% | 13.06% | 8.75% | 7.41% | 6.92% |
| Other Income | 0.11 | −0.14 | 0.82 | 0.29 | 0.18 | 0.81 | 1.19 | 0.36 | −0.38 | 0.1 | 0.13 | 0 | 0 |
| Interest | 0.31 | 0.42 | 0.55 | 0.51 | 0.45 | 0.48 | 0.56 | 0.51 | 0.44 | 0.57 | 0.3 | 0.61 | 0.59 |
| Depreciation | 0.3 | 0.21 | 0.16 | 0.15 | 0.16 | 0.27 | 0.29 | 0.28 | 0.19 | 0.16 | 0.15 | 0.06 | 0.04 |
| PBT | 0.19 | 0.52 | −0.64 | 0.36 | 1.11 | 0.62 | 0.44 | 0.56 | 0.49 | 2.5 | 1.08 | 1.44 | 1.28 |
| Tax % | 57.89% | 42.31% | −18.75% | 41.67% | 22.52% | 24.19% | 25% | 23.21% | 16.33% | 26% | 25.93% | 26.39% | — |
| Net Profit | 0.08 | 0.31 | −0.52 | 0.21 | 0.85 | 0.47 | 0.34 | 0.44 | 0.41 | 1.85 | 0.81 | 1.07 | 0.96 |
| EPS (₹) | 0.36 | 1.41 | −2.37 | 0.96 | 3.88 | 2.14 | 1.55 | 2.01 | 1.87 | 8.44 | 3.69 | 4.88 | 4.38 |
| Div. Payout % | 0% | 0% | 0% | 0% | 23.82% | 0% | 0% | 40.91% | 0% | 0% | 27.78% | 24.56% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 |
| Reserves | −0.1 | 0.21 | −0.31 | −0.1 | 0.77 | 1.07 | 1.41 | 1.85 | 2.13 | 3.77 | 4.34 | 5.2 |
| Borrowings | 2.19 | 4.45 | 4.19 | 3.79 | 1.81 | 5.51 | 5.29 | 3.99 | 2.54 | 2.08 | 2.31 | 3.1 |
| Other Liabilities | 2.67 | 7.17 | 2.35 | 4.18 | 11.93 | 8.54 | 5.63 | 3.92 | 5.05 | 7.83 | 10.25 | 12.31 |
| Total Liabilities | 7.01 | 14.08 | 8.48 | 10.12 | 16.76 | 17.37 | 14.58 | 12.01 | 11.97 | 15.93 | 19.15 | 22.86 |
| Fixed Assets | 1.06 | 1.58 | 1.38 | 1.11 | 2.1 | 1.84 | 1.55 | 1.15 | 0.37 | 0.22 | 0.26 | 0.28 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Other Assets | 5.95 | 12.5 | 7.06 | 8.97 | 14.62 | 15.49 | 12.99 | 10.82 | 11.56 | 15.67 | 18.85 | 22.54 |
| Total Assets | 7.01 | 14.08 | 8.48 | 10.12 | 16.76 | 17.37 | 14.58 | 12.01 | 11.97 | 15.93 | 19.15 | 22.86 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1.16 | 1.14 | −1.6 | 0.89 | 3.82 | −3.98 | 0.53 | 1.74 | 1.44 | 1.99 | 0.78 | −0.04 |
| Investing | −1.15 | −0.88 | 0.62 | 0.15 | −1.07 | 0.08 | 0.09 | 0.24 | 0.68 | 0.06 | −0.12 | 0.06 |
| Financing | −0.22 | −0.5 | 1.13 | 0.09 | −2.35 | 2.83 | −0.09 | −2 | −3.18 | −1.22 | −0.34 | −0.04 |
| Net Cash Flow | −0.21 | −0.23 | 0.15 | 1.13 | 0.41 | −1.07 | 0.53 | −0.03 | −1.06 | 0.83 | 0.31 | −0.02 |
| Free Cash Flow | 0.44 | 0.06 | −1.46 | 0.93 | 2.67 | −3.99 | 0.52 | 1.91 | 2.06 | 1.98 | 0.57 | −0.11 |
| CFO/OP | 186 | 105 | 191 | 127 | 260 | −684 | 530 | 187 | 113 | 79 | 97 | 13 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60.34 | 183 | 136 | 127 | 106 | 138 | 175 | 124 | 75.53 | 78.76 | 98.09 | 63.67 |
| Inventory Days | 238 | 196 | 284 | — | — | — | — | — | 281 | 186 | 469 | 279 |
| Days Payable | 201 | 204 | 161 | — | — | — | — | — | 172 | 79.83 | 382 | 174 |
| Cash Conversion Cycle | 97.07 | 176 | 259 | 127 | 106 | 138 | 175 | 124 | 184 | 185 | 185 | 169 |
| Working Capital Days | −50.53 | −34.4 | −4.86 | 0.57 | −30.99 | 25.38 | 58.83 | 57.1 | 74.7 | 67.33 | 102 | 61.11 |
| ROCE % | 12.24% | 22.93% | −0.77% | 15.74% | 28.97% | 16.11% | 11.25% | 12.09% | 23.85% | 40.88% | 16.24% | 21.09% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view A D S Diagnostic insights
65 extracted metrics across FY10–FY27.
Documents
- 10 Jan 2019
- 29 Aug 2018
Frequently Asked Questions about A D S Diagnostic
What does A D S Diagnostic Ltd do?
ADS Diagnostic supplies and trades medical equipment. The Company offers patient monitoring systems and ultrasound machines.
Where is A D S Diagnostic Ltd (ADSDIAG) listed?
A D S Diagnostic Ltd trades under code 523031 on the BSE.
Which sector does A D S Diagnostic Ltd belong to?
A D S Diagnostic Ltd is classified under the Healthcare sector, in the Healthcare Services industry.
Company Information
ADS Diagnostic supplies and trades medical equipment. The Company offers patient monitoring systems and ultrasound machines.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/523031.md for A D S Diagnostic Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.